Learn more

GUANGDONG ZHONGSHENG PHARMACY CO LTD

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    137,952
  • Filing trend
    ⇩ 88.0%
About

GUANGDONG ZHONGSHENG PHARMACY CO LTD has a total of 12 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2017. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and agriculture are GUILIN SANBAO PHARMACEUTICAL CO LTD, INTOCELL INC and INNER MONGOLIA CHANGHUI BIOTECHNOLOGY CO LTD.

Patent filings in countries

World map showing GUANGDONG ZHONGSHENG PHARMACY CO LTDs patent filings in countries
# Country Total Patents
#1 China 12

Patent filings per year

Chart showing GUANGDONG ZHONGSHENG PHARMACY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yang Jinliang 4
#2 Chen Xiaoxin 4
#3 Long Chaofeng 4
#4 Zhang Xinxuan 3
#5 Chen Lijuan 3
#6 Tan Zhenyou 3
#7 Luo Rikang 2
#8 Qian Zhiyong 2
#9 Wu Guanhua 2
#10 Chen Shuhui 2

Latest patents

Publication Filing date Title
CN110538240A Freeze-drying processing method of radix scrophulariae
CN109839001A A kind of harvesting and processing method of cattail pollen
CN109122073A A kind of implantation methods of medicinal cattail
CN108187065A Anti- 5T4 antibody and maytansine derivative DM4 coupled complexes and preparation method and purposes
CN108030783A The happy purposes cut down for Buddhist nun in the medicine for preparing prevention macular degeneration
CN109970740A 4- amidino-pyridine and azepine ring derivatives and its preparation method and application
CN107955019A A kind of salt form of EGFR inhibitor, crystal form and preparation method thereof
CN107382753A A kind of preparation method of high-purity hydrochloric acid ritodrine
CN107056859A A kind of high-purity P1, P4Two(The phosphoric acid of uridine 5 ' four)The preparation method of salt
CN108164577A A kind of P1, P4- two(Uridine -5 '-tetraphosphate)The industrialized process for preparing of sodium salt
CN108164455A The synthetic method of pheniramine maleate
CN107115344A Tyrosine kinase inhibitor is preparing the purposes in being used to prevent and/or treat the medicine of fibrotic disease